The antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a team of researchers led by the University of Huddersfield.
Jan 13 2021 Read 187 Times
Responding to the unprecedented challenge of COVID-19, Dr Syed Shahzad Hasan, senior research fellow in the Department of Pharmacy at the University of Huddersfield, in collaboration with colleagues at the University and from around the world have, since March, published over 50 articles on various aspects to dealing with the pandemic, including the safe use of medications.
“Our research team was among the first to synthesise the evidence on the use of proton pump inhibitors (1) and statins in COVID-19 patients(2),” said Dr Hasan. “These were the first to report on the safety and effectiveness of these medications in COVID-19 and were widely covered by the leading medical news outlets,” (at the time). “The idea was to generate evidence and share with a range of front-line healthcare professionals like clinicians who needed help with the evidence-based information to deal with the medical emergency. We provided them with up-to-date evidence-